Alkem Laboratories’ arm to acquire majority stake in Occlutech

13 Feb 2026 Evaluate

Alkem Laboratories’ wholly-owned medical devices subsidiary -- Alkem MedTech has executed binding offer for acquiring a majority stake in Occlutech Holding AG (Occlutech), a global medical devices company, headquartered in Switzerland, specialising in minimally invasive cardiac implants.

Alkem MedTech intends to buy up to 55% stake in Occlutech for a consideration of 99.4 million euro (around Rs 1,074 crore), subject to statutory approvals. This acquisition represents a significant step in Alkem MedTech’s journey to build a global footprint and enables its entry into advanced cardiovascular devices.

Alkem Laboratories is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments.


Alkem Laboratories Share Price

5464.05 9.75 (0.18%)
18-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.30
Dr. Reddys Lab 1280.85
Cipla 1349.10
Zydus Lifesciences 910.05
Lupin 2226.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×